ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,190Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 96

$2.21M Total Retail Price of All Prescriptions

Rank: 1 out of 96

712 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 712 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

3% of this provider’s 712 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 22,181 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$84 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
DONEPEZIL HCL 927 906 1 8
LEVOTHYROXINE SODIUM 889 793 2 3
SERTRALINE HCL 767 728 3 15
AMLODIPINE BESYLATE 692 635 4 2
FUROSEMIDE 621 575 5 4
WARFARIN SODIUM 541 454 6 6
NUEDEXTA 519 486 10 7 90
SIMVASTATIN 506 453 8 1
OMEPRAZOLE 500 435 9 5
LISINOPRIL 447 400 10 10
EXELON 446 443 11 47
RISPERIDONE 444 355 12 31
METOPROLOL SUCCINATE 411 374 13 9
QUETIAPINE FUMARATE 402 266 14 32
ENABLEX 398 381 10 15 100
METOPROLOL TARTRATE 343 298 16 7
OLANZAPINE 333 285 17 76
DIVALPROEX SODIUM 331 242 18 41
MIRTAZAPINE 324 282 19 14
NAMENDA 288 270 20 11
POTASSIUM CHLORIDE 265 236 21 19
ZOLPIDEM TARTRATE 250 207 22 18
LAMOTRIGINE 250 150 22 115
ESCITALOPRAM OXALATE 244 229 24 24
TAMSULOSIN HCL 235 179 25 29
FENTANYL 230 202 S2 26 50
TRAZODONE HCL 225 189 27 38
CITALOPRAM HBR 223 127 28 25
GABAPENTIN 221 166 29 20
DIOVAN 220 196 30 17
OXYCODONE-ACETAMINOPHEN 217 173 S2 31 26
CRESTOR 210 183 32 39
LACTULOSE 201 132 33 37
PANTOPRAZOLE SODIUM 192 174 34 44
FAMOTIDINE 189 163 35 21
OXCARBAZEPINE 171 145 36 154
HYDROCHLOROTHIAZIDE 160 136 37 16
SEROQUEL 158 120 38 106
DIGOXIN 154 154 39 34
DIVALPROEX SODIUM ER 144 55 40 171
PREDNISONE 143 99 41 58
IPRATROPIUM-ALBUTEROL 142 113 42 57
LIDODERM 139 139 43 45
LEVETIRACETAM 138 117 44 61
CYMBALTA 136 125 45 51
VIIBRYD 136 133 45 177
CARBIDOPA-LEVODOPA 133 102 47 48
NYSTATIN 127 116 48 86
LUNESTA 120 119 49 188
CARVEDILOL 120 95 49 22
CLOPIDOGREL 120 106 49 27
METFORMIN HCL 118 69 52 13
MELOXICAM 118 105 52 65
AVODART 117 97 54 190
CLOTRIMAZOLE-BETAMETHASONE 116 103 55 101
PAROXETINE HCL 115 92 56 66
LYRICA 115 115 56 73
JANUVIA 114 103 58 49
NITROGLYCERIN PATCH 111 108 59 89
BENZTROPINE MESYLATE 107 56 R 60 165
AVELOX 107 99 60 198
CIPROFLOXACIN HCL 106 87 62 97
GLIMEPIRIDE 104 91 63 43
RANITIDINE HCL 104 86 63 75
SEROQUEL XR 103 81 65 203
SINGULAIR 102 92 66 78
ATENOLOL 102 76 66 30
LOSARTAN POTASSIUM 102 90 66 23
TRAMADOL HCL 101 94 69 35
ADVAIR DISKUS 99 83 70 46
PLAVIX 98 82 71 42
ISOSORBIDE MONONITRATE ER 98 98 71 60
FINASTERIDE 95 82 73 85
VESICARE 90 75 74 121
ENALAPRIL MALEATE 89 55 75 28
CARBAMAZEPINE 88 68 76 207
SPIRIVA 88 72 76 67
LEXAPRO 87 83 78 92
ALBUTEROL SULFATE 87 60 78 83
FLUOXETINE HCL 86 36 80 107
FLUTICASONE PROPIONATE 83 58 81 55
CARAFATE 83 61 81 177
OXYBUTYNIN CHLORIDE ER 79 69 83 96
TERAZOSIN HCL 78 78 84 171
GLIPIZIDE ER 77 71 85 144
GLIPIZIDE XL 77 65 85 161
BENICAR 77 62 85 151
JANUMET 76 76 88 123
GLIPIZIDE 75 67 89 62
POLYETHYLENE GLYCOL 3350 75 67 89 53
BYSTOLIC 74 74 91 56
HUMALOG 73 45 92 120
RISPERIDONE ODT 68 48 93 231
ARICEPT 68 68 93 160
AMOX TR-POTASSIUM CLAVULANATE 67 61 95 135
PRAVASTATIN SODIUM 67 41 95 33
ACTOS 66 50 97 143
ATORVASTATIN CALCIUM 66 50 97 12
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 55 99 127
NITROFURANTOIN MONO-MACRO 62 60 100 146
MONTELUKAST SODIUM 62 51 100 137
ZIPRASIDONE HCL 62 33 100 236
NEXIUM 61 61 103 40
ALLOPURINOL 60 60 104 82
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 53 104 98
BENICAR HCT 60 58 104 243
ATELVIA 59 59 107 169
FLUPHENAZINE HCL 59 0 107 247
GALANTAMINE HBR 59 48 107 117
SANTYL 58 45 110 71
TRAVATAN Z 58 51 110 79
DILTIAZEM 24HR CD 58 51 110 83
ALENDRONATE SODIUM 58 46 110 36
LANTUS 58 40 110 68
SUCRALFATE 57 47 115 176
RAMIPRIL 57 54 115 69
AMIODARONE HCL 54 54 117 103
AZOR 54 54 117 258
LOPERAMIDE 52 47 119 159
VALPROIC ACID 50 38 120 158
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.